We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Patient-Reported Outcomes Available at Point-of-Care

By HospiMedica International staff writers
Posted on 29 Dec 2014
A new partnership enables oncology providers to easily gather and view patient reported outcome (PRO) data at the point of care (POC). More...


The integration of the Vector Oncology (Memphis, TN, USA) Patient Care Monitor and the Flatiron Health (New York, NY, USA) OncoEMR cloud-based electronic medical record (EMR) is intended to provide oncology care providers with additional insights needed to support quality of life and alleviate symptom burden for cancer patients. The Patient Care Monitor is a web-based technology platform that collects data from patients at the POC, including 86 physical symptoms across treatment side effects, impairment, acute distress, and despair and depression.

Flatiron Health and Vector Oncology will also collaborate on various studies involving health outcomes and economic endpoints in support of clinical research efforts and real-world evidence generation. In addition, Lee Schwartzberg, MD, president and chief medical officer for Vector Oncology, will serve as a medical advisor to Flatiron Health, thus helping to leverage PRO data with Flatiron's EMR platform in order to merge technology in the support of the oncology community and achieve meaningful improvements in cancer care.

“The integration of Flatiron's OncoEMR with our Patient Care Monitor will create an unmatched source of real world clinical and patient reported outcomes intelligence to improve the quality of cancer care and demonstrate the effectiveness and value of treatments,” said Mike Choukas, CEO of Vector Oncology.

“We are excited to partner with Vector Oncology, as we share a similar goal of leveraging technology to improve the quality of cancer care for patients,” said Nat Turner, co-founder and CEO of Flatiron Health. “This alliance will enable us to further support oncology providers with additional insights at the point of care.”

Related Links:

Vector Oncology
Flatiron Health



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Complete Hip System
Taperloc Complete Hip System
New
Tracheostomy Tube
Portex BLUselect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The Minder Implant can record brain activity continuously for very long periods (Photo courtesy of Epiminder)

Implantable Device Continuously Monitors Brain Activity in Epileptic Patients

Epilepsy is one of the most prevalent and serious chronic neurological disorders, impacting around 52 million people globally. It is characterized by recurrent seizures, which are caused by abnormal electrical... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.